
|Articles|August 1, 2000
Postmenopausal HRT and CHD: clinical implications of recent randomized trial res
Results of the HERS, ERA, and WHI trials suggest a conservative approach to use of HRT in women with evidence of CHD. Dose and duration of therapy may be key to the risk-benefit equation.
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Early estrogen use linked to lower disease risks
2
Digestive health symptoms common yet underrecognized during menopause transition
3
Michelle Wise, MD, discusses levonorgestrel IUD offering effective endometrial protection during hormone therapy
4
Fezolinetant shows significant real-world improvements in vasomotor symptoms, sleep
5




















